Palantir closed at $123.37 after a 15% four-week gain, yet Wall Street's average target still implies another 56.8% upside to $193.48.
Twenty-seven analyst targets cluster around that view, with a $35.16 standard deviation; estimates range from $90, implying a 27.1% drop, to $255, implying a 106.7% surge.
Earnings revisions underpin the bullish case more than price targets alone: the Zacks consensus EPS estimate for this year rose 0.7% in the past month, with one upward revision and no cuts.
Palantir also carries a Zacks Rank #2 Buy, placing it in the top 20% of more than 4,000 stocks ranked on earnings-estimate factors, though the report cautions that analyst price targets can be overly optimistic.